Skip to content

PTCT

PTC Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$69.30
−2.94%
Ask drillr
0
Insider buys (3m)
47
Insider sells (3m)
-$18.5M
Net value (3m)
-1.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 28, 2026SCHMERTZLER MICHAEL · directorSale11,890$72
Aug 28, 2026SCHMERTZLER MICHAEL · directorSale5,626$73
Aug 28, 2026SCHMERTZLER MICHAEL · directorSale610$72
Aug 28, 2026SCHMERTZLER MICHAEL · directorSale6,874$73
Aug 21, 2026SCHMERTZLER MICHAEL · directorSale7,165$74
Aug 21, 2026SCHMERTZLER MICHAEL · directorSale9,419$71
Aug 21, 2026SCHMERTZLER MICHAEL · directorSale5,335$73
Aug 21, 2026SCHMERTZLER MICHAEL · directorSale2,390$72
Aug 21, 2026SCHMERTZLER MICHAEL · directorSale691$73
Aug 19, 2026Boulding Mark Elliott · officer: EXEC. VP AND CLOSale969$73
Aug 19, 2026Boulding Mark Elliott · officer: EXEC. VP AND CLOSale1,844$72
Aug 19, 2026Boulding Mark Elliott · officer: EXEC. VP AND CLOM-Exempt2,813$26
Aug 6, 2026Klein Matthew B. · director, officer: CHIEF EXECUTIVE OFFICERSale10,292$69
Jul 30, 2026Sollie-Zetlmayer Hege Elisabeth · directorA-Award4,000$0.00
Jul 30, 2026Sollie-Zetlmayer Hege Elisabeth · directorA-Award1,738$75
Jul 30, 2026Sollie-Zetlmayer Hege Elisabeth · directorA-Award3,475$75
Jul 30, 2026Sollie-Zetlmayer Hege Elisabeth · directorA-Award2,000$0.00
Jul 16, 2026Gravier Pierre · officer: CHIEF FINANCIAL OFFICERSale3,494$80
Jul 13, 2026Smith Mary L. · directorM-Exempt10,000$43
Jul 13, 2026Almstead Neil Gregory · officer: CHIEF TECHNICAL OPS OFFICERM-Exempt2,464$47
Jul 13, 2026Almstead Neil Gregory · officer: CHIEF TECHNICAL OPS OFFICERSale2,464$90
Jul 13, 2026Smith Mary L. · directorSale5,834$90
Jul 13, 2026Smith Mary L. · directorM-Exempt5,834$43
Jul 8, 2026Almstead Neil Gregory · officer: CHIEF TECHNICAL OPS OFFICERM-Exempt24,613$39
Jul 8, 2026Boulding Mark Elliott · officer: EXEC. VP AND CLOSale833$84
Jul 8, 2026Almstead Neil Gregory · officer: CHIEF TECHNICAL OPS OFFICERSale10,090$86
Jul 8, 2026Boulding Mark Elliott · officer: EXEC. VP AND CLOSale313$83
Jul 8, 2026Boulding Mark Elliott · officer: EXEC. VP AND CLOM-Exempt2,226$39
Jul 8, 2026Boulding Mark Elliott · officer: EXEC. VP AND CLOSale387$83
Jul 8, 2026Almstead Neil Gregory · officer: CHIEF TECHNICAL OPS OFFICERSale2,474$87
Institutional positioning

13F filings over the trailing two quarters

New 139Increased 288Reduced 219Sold out 45
FilerActionSharesFiled
BlackRock, Inc.Increased13,964,554Aug 7, 2026
BLACKROCK, INC.Increased12,948,717May 13, 2026
RTW INVESTMENTS, LPUnchanged7,746,415Aug 14, 2026
RTW INVESTMENTS, LPUnchanged7,746,415May 15, 2026
Jupiter Topco LLCNew Position7,236,402Aug 14, 2026
JANUS HENDERSON GROUP PLCIncreased7,193,433May 18, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased4,928,111Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position4,804,594May 8, 2026
STATE STREET CORPIncreased4,598,952Aug 7, 2026
STATE STREET CORPIncreased4,346,519May 15, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased4,128,273Aug 14, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased3,942,610May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased3,739,127Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position3,676,256May 15, 2026
TORONTO DOMINION BANKReduced3,025,963May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 28, 2026